| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.096 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.27 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.43 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.49 | 0.09 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -2.4e-06 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -6e-05 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 6.6e-05 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |